Greater endurance enhanced ability to maintain effort over time due to more efficient oxygen utilization
This section explores how microbial rhythms arise, how they are perturbed by circadian misalignment, and how they participate in the gutliver metabolic axis relevant to MASLD (5052)
At week 88, patients receiving tirzepatide lost an additional 6.7% of their mean body weight from randomization, while patients receiving placebo gained 14.8% of their mean body weight, for a placebo-adjusted net weight change of -21.4%
When SMG was compared to other GLP-1 receptor agonist medications (exenatide extended-release, dulaglutide, and liraglutide), SMG showed greater weight loss [71,72,73]
4, participants reporting reduced cravings had the longest median duration of GLP-1 use (approximately 20 months), followed by those reporting no change (approximately 12 months)
Bitter or Off Flavors: Foods that you previously enjoyed may suddenly taste overly bitter or sour